Cite

HARVARD Citation

    Si, X. et al. (2019). Management of anlotinib‐related adverse events in patients with advanced non‐small cell lung cancer: Experiences in ALTER‐0303. Thoracic cancer. 10 (3), pp. 551-556. [Online]. 
  
Back to record